KCLB No. | 00761 |
---|---|
Name | SNU-761 |
Origin | liver |
---|---|
Species | human, asian - male, 49 years old |
Cellular morphology | polygonal |
Growth pattern | monolayer |
Histopathology | hepatocellular carcinoma |
Depositor | Jae-Gahb Park, M.D. |
Cell viability | 91% |
D3S1358: 15,17 |
vWA: 16 |
FGA: 23,24 |
Amelogenin: X,Y |
TH01: 9 |
TPOX: 11 |
CSF1PO: 12 |
D5S818: 9,12 |
D13S317: 10 |
D7S820: 9 |
Freezing media | RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5% |
---|---|
Original media | RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10% |
KCLB media | RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10% |
Subculture | Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37''C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask |
Populaton doubling time | 24 hours |
Split ratio | 1:4 |
Media change | Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days |
Lee et al., Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virud DNA, World J Gastroenterology. 1999, 5:289-295 |
|
Korean Cell Line Bank, Korean Cell Line Research Foundation,
101, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
대표자 : 박재갑 | 개인정보보안책임자 : 신영경 | 사업자 등록번호 : 208-82-03887
통신판매업 신고 제2015-서울혜화-0125호 | Tel : 82-2-3668-7915
Fax : 82-2-742-0021 | Email : kclb@kclb.kr
KCLB (C) is a registered mark of Korean Cell Line Bank. All rights reserved. 1998~2015